Increased sophistication of immunotoxins.
Frankel
Arthur E
AE
D000911:Antibodies, Monoclonal / Q000235:genetics / Q000494:pharmacology*; D015703:Antigens, CD / Q000276:immunology*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology*; D015815:Cell Adhesion Molecules; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000494:pharmacology; D000922:Immunotoxins / Q000235:genetics / Q000276:immunology / Q000494:pharmacology*; D020128:Inhibitory Concentration 50; D037102:Lectins; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D014176:Protein Biosynthesis; D011506:Proteins / Q000187:drug effects; D051918:Sialic Acid Binding Ig-like Lectin 2; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; C497867:CD22 protein, human; D015815:Cell Adhesion Molecules; D007128:Immunoglobulin Fragments; D000922:Immunotoxins; D037102:Lectins; D011506:Proteins; D051918:Sialic Acid Binding Ig-like Lectin 2; C055966:immunoglobulin Fv